Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
J Obstet Gynaecol Res ; 41(9): 1357-62, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26017244

ABSTRACT

AIM: The aim of this study was to evaluate the performance of in-house real-time polymerase chain reaction (qPCR) in detecting group B streptococcus (GBS) colonization compared with the standard culture method in a cohort of pregnant women. MATERIAL AND METHODS: A total of 134 rectovaginal swabs were collected from 125 pregnant women, of whom 108 were known carriers or presented with preterm prelabor rupture of membranes. The swabs were placed in Standard Methods Broth (Todd-Hewitt broth supplemented with 6 µg/mL gentamicin and 15 µg/mL nalidixic acid) for culture identification of GBS. An in-house qPCR was also performed from the broth and after overnight incubation of the broth. RESULTS: The detection rate of GBS in this cohort was 30.6% and 50.7% using standard culture method and qPCR, respectively. GBS-specific qPCR assay gave sensitivities of 97.6% and 100%, specificities of 73.1% and 71.0%, and negative predictive values of 98.6% and 100% from direct specimen and from broth after overnight incubation, respectively. CONCLUSIONS: The in-house qPCR test has high sensitivity in detecting GBS colonization. The high negative predictive value helps to avoid unnecessary use of antibiotics in uncolonized women.


Subject(s)
Pregnancy Complications, Infectious/diagnosis , Real-Time Polymerase Chain Reaction/methods , Streptococcal Infections/diagnosis , Streptococcus agalactiae/isolation & purification , Adult , Female , Humans , Predictive Value of Tests , Pregnancy , Pregnant Women , Sensitivity and Specificity
3.
Obstet Gynecol ; 124(5): 897-903, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25437716

ABSTRACT

OBJECTIVE: To evaluate the efficacy of transcervical intralesional vasopressin injection to submucous myoma in hysteroscopic myomectomy from 2011 to 2014. METHODS: This was a prospective, randomized, double-blind study in a single center. Forty premenopausal women with symptomatic submucous myoma requiring hysteroscopic myomectomy were randomized to transcervical intralesional vasopressin injection or placebo in a 4:4 ratio. The primary outcome was operative time. Secondary outcomes including fluid volumes, blood loss, and visual clarity were compared between the two groups. RESULTS: The median duration for myomectomy was 19.9 minutes (range 3.1-54.2 minutes) in the vasopressin group compared with 29.0 minutes (range 8.0-60.9 minutes) in the placebo group, a nonsignificant difference (P=.14). There were significant reductions in the median volume of fluid used (4,200 mL [range 1,300-21,000 mL] compared with 9,800 mL (range 1,500-23,000 mL; P=.004) and fluid intravasation (0 mL [range 0-3,100] compared with 300 mL [range -150-3,150 mL; P=.029) in the vasopressin group. The median intraoperative blood loss was reduced (5 mL [range 1-50 mL] compared with 20 mL [range 1-150 mL; P=.002). The operative surgeon rated that 95% of the vasopressin group had "minimal" bleeding compared with 36.8% in the placebo group. The surgical field (visual analog scale [VAS] 9 [range 2-10] compared with 6 [range 2-10; P<.001]; 0=worst visual clarity, 10=best visual clarity) and the effluent fluid (VAS 1 [range 0-7] compared with 4 [range 0-8; P<.001]; 0=clear, 10=unclear) were statistically significantly clearer in the vasopressin group. CONCLUSION: Transcervical intralesional vasopressin injection in hysteroscopic myomectomy did not reduce operative time but did reduce volume of inflow fluid, fluid intravasation, intraoperative blood loss, and improving visual clarity. CLINICAL TRIAL REGISTRATION: Centre for Clinical Research and Biostatistics, http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx, CUHK_CCT00291.


Subject(s)
Leiomyoma/drug therapy , Uterine Neoplasms/drug therapy , Vasoconstrictor Agents/administration & dosage , Vasopressins/administration & dosage , Adult , Blood Loss, Surgical , Cervix Uteri , Double-Blind Method , Female , Humans , Hysteroscopy , Injections, Intralesional , Leiomyoma/pathology , Leiomyoma/surgery , Middle Aged , Prospective Studies , Time Factors , Treatment Outcome , Uterine Myomectomy , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery
4.
Taiwan J Obstet Gynecol ; 53(2): 210-4, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25017269

ABSTRACT

OBJECTIVE: To compare the incidence of neonatal group B streptococcus (GBS) infection in active GBS carriers with preterm prelabor rupture of membranes (PPROMs) after penicillins and erythromycin prophylaxis. MATERIALS AND METHODS: Patients diagnosed to have PPROM between 2004 and 2009 inclusive were treated using erythromycin (erythromycin group), ampicillin, amoxicillin or co-amoxiclav (penicillin group), or no antibiotics (control group) according to department protocols depending on their gestation and their GBS status at the time of presentation. Patients receiving both erythromycin and penicillins were included in the penicillin group. The incidence of neonatal GBS infection was compared between groups categorized according to the antibiotic regime received. RESULTS: A total of 680 women were diagnosed to have PPROM of which 85 (12.5%) were active GBS carriers. GBS isolates were 100% sensitive to penicillins but only 35% were sensitive to erythromycin. There were 16, 22, and 47 patients in the penicillin, erythromycin, and control groups, respectively. The incidence of neonatal GBS infection in the three groups was 0%, 36%, and 13%, respectively, and was statistically significant (p = 0.023). CONCLUSION: Penicillins are more effective than erythromycin in preventing neonatal GBS infection in women with PPROM who were active GBS carriers. Because most women do not know their GBS status at the time of PPROM and it is practically difficult to identify the active carriers before delivery, ampicillin/amoxicillin should be used as a prophylactic antibiotic for active GBS carriers and women with unknown GBS carriage status to prevent neonatal GBS infection following PPROM.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Erythromycin/therapeutic use , Infectious Disease Transmission, Vertical/prevention & control , Penicillins/therapeutic use , Streptococcal Infections/transmission , Streptococcus agalactiae , Adult , Carrier State/drug therapy , Carrier State/microbiology , Female , Fetal Membranes, Premature Rupture/microbiology , Humans , Infant, Newborn , Pregnancy , Streptococcal Infections/prevention & control
5.
Menopause ; 21(8): 794-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24473531

ABSTRACT

OBJECTIVE: This study aims to examine the prevalence and bacteriological findings of different types of intrauterine fluid collection in women presenting with postmenopausal bleeding and the risk factors for predicting positive microbiological culture, mixed growth, and anaerobic growth. METHODS: This is a retrospective cohort study. Data from all of the women who were assessed in our one-stop postmenopausal bleeding clinic between 2008 and 2011 and who were found to have intrauterine fluid collection were reviewed. Endometrial aspirates of all women were sent for bacterial culture and histological examination. The risk factors for positive culture were assessed by both univariate and multivariate analyses. RESULTS: A total of 228 cases of intrauterine fluid collection were included for analysis. There were 109 (47.8%) cases of pyometra, 98 (43.0%) cases of hydrometra, and 21 (9.2%) cases of hematometra. Escherichia coli, Bacteroides fragilis, and Enterococcus were the commonest microorganisms isolated from endometrial aspirates. Both endometrial malignancy and benign intrauterine pathologies are not risk factors for positive culture. Advanced age (>75 y) is an independent risk factor for positive culture (odds ratio, 2.89; 95% CI, 1.39-6.01) and mixed growth (odds ratio, 2.18; 95% CI, 1.02-4.67). Residency in nursing homes is an independent risk factor for mixed growth (odds ratio, 2.61; 95% CI, 1.21-5.63) and anaerobic growth (odds ratio, 2.55; 95% CI, 1.01-6.44). CONCLUSIONS: E. coli, B. fragilis, and Enterococcus are the commonest microorganisms isolated from intrauterine fluid. Apart from drainage of the intrauterine fluid collection, successful management also requires appropriate antibiotics and improvement in perineal hygiene.


Subject(s)
Postmenopause , Uterine Hemorrhage/epidemiology , Vaginosis, Bacterial/epidemiology , Age Factors , Aged , Body Fluids/microbiology , Cohort Studies , Female , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Hong Kong/epidemiology , Humans , Prevalence , Retrospective Studies , Risk Factors , Uterine Hemorrhage/microbiology , Vaginosis, Bacterial/microbiology
6.
J Laparoendosc Adv Surg Tech A ; 23(3): 258-62, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23343201

ABSTRACT

An original technique of transcervical intralesional vasopressin injection that allowed direct infiltration to submucous myomas under hysteroscopic control is described. Five patients with a symptomatic submucous myoma 1.5-5 cm in size scheduled for hysteroscopic myomectomy were recruited. The time required for vasopressin injection was less than 3 minutes in all cases. The time required for myomectomy ranged from 3 to 32 minutes. Four cases had no fluid absorption, whereas 1 had absorption of 1000 mL. The patient with the longest operative time and fluid absorption had multiple submucous myomas, including a large G2 myoma of 5 cm. All cases had complete excision without complication. The surgeons rated the operations as having minimal bleeding and excellent clarity. Transcervical intralesional vasopressin injection is a potentially simple, quick, and feasible method to facilitate complete resection of submucous myomas in hysteroscopic myomectomy.


Subject(s)
Hysteroscopy , Uterine Myomectomy/methods , Vasoconstrictor Agents/administration & dosage , Vasopressins/administration & dosage , Adult , Cervix Uteri , Female , Humans , Injections, Intralesional , Middle Aged
7.
Aust N Z J Obstet Gynaecol ; 52(2): 167-72, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22251144

ABSTRACT

BACKGROUND: The management of antepartum haemorrhage of unknown origin (APHUO) remote from term remains controversial. AIM: To determine the rate and risk factors in predicting preterm delivery among women presenting with APHUO before 34 weeks of gestation. METHODS: All singleton pregnancies with the first episode of APHUO before 34 weeks of gestation who delivered between January 1995 and December 2004 were reviewed. The predictability of risk factors was assessed by both univariate and multivariate analysis. The cumulative rates of preterm delivery prior to 34 weeks were compared by using the Kaplan-Meier survival analysis and log-rank test between those with and those without risk factors. RESULTS: The rates of preterm delivery prior to 34 and 37 weeks of gestation were 7.3 and 17%, respectively. Uterine contractions, persistent bleeding, two or more episodes of APHUO and a history of spontaneous preterm deliveries were significant risk factors for preterm birth prior to 34 weeks in a multivariate logistic regression. Women with one risk factor had a hazard ratio of 5.5 (95% CI: 3.2-9.6) in having preterm delivery prior to 34 weeks compared with those without risk factors, whereas women with any two risk factors had a hazard ratio of 5.2 (95% CI: 2.1-12.9) compared with those with one risk factor. CONCLUSIONS: APHUO prior to 34 weeks of gestation is associated with three to fivefold increased risk of preterm delivery. Identification of several risk factors could further help to predict early preterm delivery and appropriate triage management.


Subject(s)
Premature Birth/epidemiology , Uterine Hemorrhage/epidemiology , Adult , Female , Humans , Incidence , Infant, Newborn , Infant, Premature , Obstetric Labor, Premature/epidemiology , Pregnancy , Retrospective Studies , Risk , Uterine Contraction
8.
Int J Gynaecol Obstet ; 106(3): 232-5, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19428008

ABSTRACT

OBJECTIVE: To determine the prevalence of a history of hepatitis B vaccination among pregnant Chinese women in Hong Kong, and to identify factors associated with vaccine uptake at their own expense. METHODS: A prospective, cross-sectional survey was conducted in a university obstetric unit in Hong Kong. Pregnant Chinese women who attended the prenatal clinic were invited to complete a self-administered questionnaire, which requested details of their history of hepatitis B vaccination and sociodemographic characteristics. RESULTS: The prevalence of hepatitis B vaccine uptake was 33%. The following factors were associated with higher hepatitis B vaccine uptake: employment as a healthcare worker; a higher education level; higher monthly family income; routine medical checkups; and premarital checkups. CONCLUSION: The findings suggest that the public has insufficient awareness of hepatitis B infection in the community and that providing better information and education to the general public is necessary.


Subject(s)
Hepatitis B Vaccines , Immunization Programs/statistics & numerical data , Medication Adherence/statistics & numerical data , Adult , Asian People , Female , Health Knowledge, Attitudes, Practice , Health Surveys , Hong Kong , Humans , Pregnancy , Prospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...